224 related articles for article (PubMed ID: 34477780)
1. Combining PD-L1 inhibitors with immunogenic cell death triggered by chemo-photothermal therapy via a thermosensitive liposome system to stimulate tumor-specific immunological response.
Yu J; He X; Wang Z; Wang Y; Liu S; Li X; Huang Y
Nanoscale; 2021 Aug; 13(30):12966-12978. PubMed ID: 34477780
[TBL] [Abstract][Full Text] [Related]
2. Correction: Combining PD-L1 inhibitors with immunogenic cell death triggered by chemo-photothermal therapy via a thermosensitive liposome system to stimulate tumor-specific immunological response.
Yu J; He X; Wang Z; Wang Y; Liu S; Xie Z; Li X; Huang Y
Nanoscale; 2021 Aug; 13(32):13907. PubMed ID: 34477666
[TBL] [Abstract][Full Text] [Related]
3. Multifunctional Nanoplatform-Mediated Chemo-Photothermal Therapy Combines Immunogenic Cell Death with Checkpoint Blockade to Combat Triple-Negative Breast Cancer and Distant Metastasis.
Zhu H; Yang K; Yao H; Chen X; Yan S; He Y; Cao Y; Luo J; Wang D
Int J Nanomedicine; 2023; 18():3109-3124. PubMed ID: 37323948
[TBL] [Abstract][Full Text] [Related]
4. Metal-organic framework-mediated multifunctional nanoparticles for combined chemo-photothermal therapy and enhanced immunotherapy against colorectal cancer.
Liu H; Xu C; Meng M; Li S; Sheng S; Zhang S; Ni W; Tian H; Wang Q
Acta Biomater; 2022 May; 144():132-141. PubMed ID: 35307591
[TBL] [Abstract][Full Text] [Related]
5. Targeting of focal adhesion kinase enhances the immunogenic cell death of PEGylated liposome doxorubicin to optimize therapeutic responses of immune checkpoint blockade.
Zhang B; Li N; Gao J; Zhao Y; Jiang J; Xie S; Zhang C; Zhang Q; Liu L; Wang Z; Ji D; Wu L; Ren R
J Exp Clin Cancer Res; 2024 Feb; 43(1):51. PubMed ID: 38373953
[TBL] [Abstract][Full Text] [Related]
6. Anti-PD-L1 peptide-conjugated prodrug nanoparticles for targeted cancer immunotherapy combining PD-L1 blockade with immunogenic cell death.
Moon Y; Shim MK; Choi J; Yang S; Kim J; Yun WS; Cho H; Park JY; Kim Y; Seong JK; Kim K
Theranostics; 2022; 12(5):1999-2014. PubMed ID: 35265195
[No Abstract] [Full Text] [Related]
7. Combination of Chidamide-Mediated Epigenetic Modulation with Immunotherapy: Boosting Tumor Immunogenicity and Response to PD-1/PD-L1 Blockade.
Tu K; Yu Y; Wang Y; Yang T; Hu Q; Qin X; Tu J; Yang C; Kong L; Zhang Z
ACS Appl Mater Interfaces; 2021 Aug; 13(33):39003-39017. PubMed ID: 34433253
[TBL] [Abstract][Full Text] [Related]
8. Selectively down-regulated PD-L1 by albumin-phenformin nanoparticles mediated mitochondrial dysfunction to stimulate tumor-specific immunological response for enhanced mild-temperature photothermal efficacy.
Zhou Z; Jiang N; Chen J; Zheng C; Guo Y; Ye R; Qi R; Shen J
J Nanobiotechnology; 2021 Nov; 19(1):375. PubMed ID: 34794446
[TBL] [Abstract][Full Text] [Related]
9. NIR-II light evokes DNA cross-linking for chemotherapy and immunogenic cell death.
Huang Y; Wei D; Wang B; Tang D; Cheng A; Xiao S; Yu Y; Huang W
Acta Biomater; 2023 Apr; 160():198-210. PubMed ID: 36792048
[TBL] [Abstract][Full Text] [Related]
10. Oxaliplatin induces immunogenic cell death in hepatocellular carcinoma cells and synergizes with immune checkpoint blockade therapy.
Zhu H; Shan Y; Ge K; Lu J; Kong W; Jia C
Cell Oncol (Dordr); 2020 Dec; 43(6):1203-1214. PubMed ID: 32797385
[TBL] [Abstract][Full Text] [Related]
11. Reversing Immune Suppression and Potentiating Photothermal Immunotherapy via Bispecific Immune Checkpoint Inhibitor Loaded Hollow Polydopamine Nanospheres.
Guo K; Chen D; Ren S; Younis MR; Teng Z; Zhang L; Wang Z; Tian Y
ACS Appl Mater Interfaces; 2023 Mar; ():. PubMed ID: 36881613
[TBL] [Abstract][Full Text] [Related]
12. Local and Targeted Delivery of Immune Checkpoint Blockade Therapeutics.
Han X; Li H; Zhou D; Chen Z; Gu Z
Acc Chem Res; 2020 Nov; 53(11):2521-2533. PubMed ID: 33073988
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of immunogenic cell death and immune checkpoint blockade therapy.
Lin RA; Lin JK; Lin SY
Kaohsiung J Med Sci; 2021 Jun; 37(6):448-458. PubMed ID: 33636043
[TBL] [Abstract][Full Text] [Related]
14. Near-Infrared II Nanoadjuvant-Mediated Chemodynamic, Photodynamic, and Photothermal Therapy Combines Immunogenic Cell Death with PD-L1 Blockade to Enhance Antitumor Immunity.
Xiang Q; Yang C; Luo Y; Liu F; Zheng J; Liu W; Ran H; Sun Y; Ren J; Wang Z
Small; 2022 Apr; 18(13):e2107809. PubMed ID: 35143709
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel derivative-based liposomal nanoplatform for potentiated chemo-immunotherapy.
Wang Y; Yu J; Li D; Zhao L; Sun B; Wang J; Wang Z; Zhou S; Wang M; Yang Y; Liu H; Zhang H; Lv Q; Jiang Q; He Z; Wang Y
J Control Release; 2022 Jan; 341():812-827. PubMed ID: 34953979
[TBL] [Abstract][Full Text] [Related]
16. Liposome-mediated PD-L1 multivalent binding promotes the lysosomal degradation of PD-L1 for T cell-mediated antitumor immunity.
Yang S; Shim MK; Song S; Cho H; Choi J; Jeon SI; Kim WJ; Um W; Park JH; Yoon HY; Kim K
Biomaterials; 2022 Nov; 290():121841. PubMed ID: 36206664
[TBL] [Abstract][Full Text] [Related]
17. Photothermal therapies to improve immune checkpoint blockade for cancer.
Balakrishnan PB; Sweeney EE; Ramanujam AS; Fernandes R
Int J Hyperthermia; 2020 Dec; 37(3):34-49. PubMed ID: 33426992
[TBL] [Abstract][Full Text] [Related]
18. Low-temperature photothermal irradiation triggers alkyl radicals burst for potentiating cancer immunotherapy.
Ning B; Liu Y; Ouyang B; Su X; Guo H; Pang Z; Shen S
J Colloid Interface Sci; 2022 May; 614():436-450. PubMed ID: 35108635
[TBL] [Abstract][Full Text] [Related]
19. Near-Infrared II Phototherapy Induces Deep Tissue Immunogenic Cell Death and Potentiates Cancer Immunotherapy.
Ma Y; Zhang Y; Li X; Zhao Y; Li M; Jiang W; Tang X; Dou J; Lu L; Wang F; Wang Y
ACS Nano; 2019 Oct; 13(10):11967-11980. PubMed ID: 31553168
[TBL] [Abstract][Full Text] [Related]
20. Photothermal-Activatable Fe
Ge R; Liu C; Zhang X; Wang W; Li B; Liu J; Liu Y; Sun H; Zhang D; Hou Y; Zhang H; Yang B
ACS Appl Mater Interfaces; 2018 Jun; 10(24):20342-20355. PubMed ID: 29878757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
